Yasunobu Okuma Selected Research

Yasunobu Okuma Research Topics

Disease

6	Body Weight (Weight, Body) 12/2006 - 02/2002
5	Alzheimer Disease (Alzheimer's Disease) 01/2014 - 03/2003
4	Hypoxia (Hypoxemia) 01/2023 - 10/2004
4	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2019 - 05/2008
4	Brain Ischemia (Cerebral Ischemia) 01/2015 - 10/2002
4	Parkinsonian Disorders (Parkinsonism) 01/2012 - 06/2006
4	Ischemia 11/2004 - 01/2002
3	Inflammation (Inflammations) 10/2005 - 02/2002
3	Infections 10/2005 - 02/2002
2	Carcinoma (Carcinomatosis) 01/2023 - 09/2014
2	Brain Injuries (Brain Injury) 01/2015 - 01/2002
2	Inborn Urea Cycle Disorders 01/2012 - 10/2004
2	Pheochromocytoma 04/2005 - 07/2002
2	Neuroblastoma 11/2004 - 10/2004
2	Infarction (Infarctions) 10/2004 - 10/2004
2	Anorexia 08/2003 - 02/2002
1	Starvation 01/2023
1	Autism Spectrum Disorder 01/2016
1	Parkinson Disease (Parkinson's Disease) 02/2015
1	Virus Diseases (Viral Diseases) 01/2012
1	Neoplasms (Cancer) 01/2012
1	Adenocarcinoma of Lung 01/2010
1	Necrosis 03/2008
1	Weight Loss (Weight Reduction) 06/2007
1	Tauopathies 06/2007
1	Thalassemia 10/2004
1	Stroke (Strokes) 10/2004
1	Edema (Dropsy) 10/2004
1	Sickle Cell Anemia (Hemoglobin S Disease) 10/2004
1	Cystic Fibrosis (Mucoviscidosis) 10/2004
1	Fever (Fevers) 02/2002

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2004
6	LeptinIBA 12/2006 - 02/2002
3	Messenger RNA (mRNA)IBA 01/2023 - 01/2002
3	4-phenylbutyric acid (Buphenyl)FDA Link 02/2015 - 10/2004
3	4-phenylbutylamineIBA 01/2012 - 10/2004
3	Endothelin Receptors (Endothelin Receptor)IBA 01/2012 - 06/2006
2	Ligases (Synthetase)IBA 01/2014 - 01/2012
2	UbiquitinIBA 01/2014 - 01/2012
2	Amyloid (Amyloid Fibrils)IBA 01/2014 - 03/2010
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2012 - 10/2004
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 05/2008 - 12/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2008 - 10/2004
2	InterleukinsIBA 08/2003 - 02/2002
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	NeuroliginsIBA 01/2016
1	naphthaleneIBA 02/2015
1	EpiregulinIBA 01/2015
1	Epidermal Growth Factor (EGF)IBA 01/2015
1	AmphiregulinIBA 01/2015
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2014
1	Casein Kinase II (Casein Kinase 2)IBA 01/2012
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2012
1	Amyloid beta-PeptidesIBA 03/2010
1	GenisteinIBA 01/2010
1	Tyrosine Kinase InhibitorsIBA 01/2010
1	hexanoic acid (hexanoate)IBA 01/2010
1	CeramidasesIBA 01/2010
1	N- (7- (4- nitrobenzo- 2- oxa- 1,3- diazole))- 6- aminocaproyl sphingosineIBA 01/2010
1	N- 4- nitrobenzo- 2- oxa- 1,3- diazoleaminocaproyl sphingosylphosphorylcholineIBA 01/2010
1	ceramide kinaseIBA 01/2010
1	herbimycinIBA 01/2010
1	SphingosineIBA 01/2010
1	CaspasesIBA 03/2008
1	RotenoneIBA 06/2007
1	CystatinsIBA 10/2005
1	Indicators and Reagents (Reagents)IBA 04/2005
1	oxophenylarsine (phenylarsine oxide)IBA 04/2005
1	Arachidonic Acid (Vitamin F)IBA 04/2005
1	Endoplasmic Reticulum Chaperone BiPIBA 11/2004
1	interleukin 20 (IL-20)IBA 11/2004
1	Caspase 12IBA 10/2004
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2004
1	Free Radical ScavengersIBA 10/2004
1	EdaravoneIBA 10/2004
1	CytokinesIBA 03/2003
1	Carrier Proteins (Binding Protein)IBA 10/2002
1	ElementsIBA 10/2002
1	Cyclic AMP (AMP, Cyclic)IBA 10/2002
1	Janus KinasesIBA 09/2002
1	Tyrosine (L-Tyrosine)FDA Link 07/2002
1	Prostaglandins FIBA 07/2002
1	ProstaglandinsIBA 07/2002
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 07/2002
1	Vanadates (Orthovanadate)IBA 07/2002
1	salicylhydroxamic acid (SHAM)IBA 01/2002
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2002
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2002

Therapy/Procedure

1	Therapeutics 01/2015